Drugs five years later. Cisplatin.

Research output: Contribution to journalArticle

1037 Citations (Scopus)

Abstract

Cisplatin is a metal coordination compound that was approved for clinical use in treating testicular cancer 5 years ago. Although early trials showed marked gastrointestinal and renal toxicities, treatment-related morbidity has been significantly alleviated with modern antiemetic therapy and adequate pretreatment hydration. More recent clinical studies of cisplatin have shown a broad range of activity and provide a better understanding of the drug's pharmacology, mechanism of action, and toxicity. Variations in the dosage and mode of administration as well as development of cisplatin analogues are being currently studied.

Original languageEnglish
Pages (from-to)704-713
Number of pages10
JournalAnnals of Internal Medicine
Volume100
Issue number5
StatePublished - May 1984

Fingerprint

Cisplatin
Pharmaceutical Preparations
Antiemetics
Testicular Neoplasms
Metals
Pharmacology
Morbidity
Kidney
Therapeutics
Clinical Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Drugs five years later. Cisplatin. / Loehrer, Patrick; Einhorn, Lawrence.

In: Annals of Internal Medicine, Vol. 100, No. 5, 05.1984, p. 704-713.

Research output: Contribution to journalArticle

@article{1a4554c41b194defa199fa728dafccf6,
title = "Drugs five years later. Cisplatin.",
abstract = "Cisplatin is a metal coordination compound that was approved for clinical use in treating testicular cancer 5 years ago. Although early trials showed marked gastrointestinal and renal toxicities, treatment-related morbidity has been significantly alleviated with modern antiemetic therapy and adequate pretreatment hydration. More recent clinical studies of cisplatin have shown a broad range of activity and provide a better understanding of the drug's pharmacology, mechanism of action, and toxicity. Variations in the dosage and mode of administration as well as development of cisplatin analogues are being currently studied.",
author = "Patrick Loehrer and Lawrence Einhorn",
year = "1984",
month = "5",
language = "English",
volume = "100",
pages = "704--713",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "5",

}

TY - JOUR

T1 - Drugs five years later. Cisplatin.

AU - Loehrer, Patrick

AU - Einhorn, Lawrence

PY - 1984/5

Y1 - 1984/5

N2 - Cisplatin is a metal coordination compound that was approved for clinical use in treating testicular cancer 5 years ago. Although early trials showed marked gastrointestinal and renal toxicities, treatment-related morbidity has been significantly alleviated with modern antiemetic therapy and adequate pretreatment hydration. More recent clinical studies of cisplatin have shown a broad range of activity and provide a better understanding of the drug's pharmacology, mechanism of action, and toxicity. Variations in the dosage and mode of administration as well as development of cisplatin analogues are being currently studied.

AB - Cisplatin is a metal coordination compound that was approved for clinical use in treating testicular cancer 5 years ago. Although early trials showed marked gastrointestinal and renal toxicities, treatment-related morbidity has been significantly alleviated with modern antiemetic therapy and adequate pretreatment hydration. More recent clinical studies of cisplatin have shown a broad range of activity and provide a better understanding of the drug's pharmacology, mechanism of action, and toxicity. Variations in the dosage and mode of administration as well as development of cisplatin analogues are being currently studied.

UR - http://www.scopus.com/inward/record.url?scp=0021435857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021435857&partnerID=8YFLogxK

M3 - Article

VL - 100

SP - 704

EP - 713

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 5

ER -